๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II study of bortezomib in the treatment of metastatic malignant melanoma

โœ Scribed by Svetomir N. Markovic; Susan M. Geyer; Fitzroy Dawkins; William Sharfman; Mark Albertini; William Maples; Paula M. Fracasso; Tom Fitch; Patricia LoRusso; Alex A. Adjei; Charles Erlichman

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
86 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II trial of taxol in metastatic
A phase II trial of taxol in metastatic melanoma
โœ Sewa S. Legha; Sigrid Ring; Nicholas Papadopoulos; Martin Raber; Robert S. Benja ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 321 KB ๐Ÿ‘ 2 views
A phase II study of autologous irradiate
A phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanoma
โœ J. Frederick Laucius; Audley J. Bodurtha; Michael J. Mastrangelo; Robert E. Bell ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 285 KB ๐Ÿ‘ 2 views

Eighteen patients with surgically incurable metastatic malignant melanoma were treated with a mixture of irradiated (15,000 rads) autologous tumors cells (1-2 X 10(8)) and BCG (Glaxo, 2-4.5 X 10(6) organisms), which was injected intradermally (in five divided doses) every 2 weeks (X5). Four of 18 (2